A two-centre open-label non-inferiority trial to assess the immunogenicity and safety of an intradermal and an intramuscular single-visit dosing regimen of purified chick-embryo cell-culture rabies vaccine in adults
Latest Information Update: 10 Apr 2024
At a glance
- Drugs Rabies vaccine (Primary) ; Rabies vaccine (Primary)
- Indications Rabies
- Focus Therapeutic Use
- Acronyms SingleR
Most Recent Events
- 10 Oct 2022 New trial record